FGEN: FibroGen Inc
FGEN exchange rate has changed by 7.65% for today. During the day, the instrument was traded at a low of 9.23 and at a high of 9.75.
Follow FibroGen Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H4
- D1
- W1
- MN
FGEN News
- FibroGen stock rises after announcing rebrand to Kyntra Bio
- FibroGen rebrands as Kyntra Bio with new Nasdaq ticker KYNB
- FDA grants orphan drug designation to FibroGen’s roxadustat for MDS
- FibroGen stock rises after roxadustat receives Orphan Drug Designation
- Fibrogen CEO Wettig Thane buys shares worth $33,749
- FibroGen, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:FGEN) 2025-11-11
- FibroGen, Inc. (FGEN) Q3 2025 Earnings Call Transcript
- FibroGen (FGEN) Reports Q3 Loss, Lags Revenue Estimates
- H.C. Wainwright reiterates Buy rating on Connect Biopharma stock at $7 target
- FibroGen stock advances as H.C. Wainwright reiterates Buy rating on FG-3246 progress
- FibroGen initiates phase 2 trial of FG-3246 for prostate cancer
- FibroGen completes $220 million sale of Hong Kong subsidiary to AstraZeneca
- FibroGen stock maintains Buy rating at H.C. Wainwright after China sale
- China approves FibroGen’s sale to AstraZeneca, closing expected in Q3
- FibroGen, Inc. (FGEN) Q2 2025 Earnings Call Transcript
- FibroGen (FGEN) Reports Q2 Loss, Lags Revenue Estimates
- FibroGen Q2 2025 slides: China sale extends runway amid clinical progress
- Earnings call transcript: FibroGen Q2 2025 revenue falls short, stock drops
- FibroGen Inc earnings missed by $1.79, revenue fell short of estimates
- FibroGen stock surges after FDA feedback on roxadustat for MDS anemia
- FibroGen advances roxadustat for anemia in myelodysplastic syndromes
- Connect Biopharma appoints James A. Schoeneck to board of directors
- FibroGen amends financing agreement to reduce minimum cash balance requirement
Frequently Asked Questions
What is FGEN stock price today?
FibroGen Inc stock is priced at 9.71 today. It trades within 9.23 - 9.75, yesterday's close was 9.02, and trading volume reached 79. The live price chart of FGEN shows these updates.
Does FibroGen Inc stock pay dividends?
FibroGen Inc is currently valued at 9.71. Dividend policy depends on the company, while investors also watch 2057.78% and USD. View the chart live to track FGEN movements.
How to buy FGEN stock?
You can buy FibroGen Inc shares at the current price of 9.71. Orders are usually placed near 9.71 or 10.01, while 79 and 5.20% show market activity. Follow FGEN updates on the live chart today.
How to invest into FGEN stock?
Investing in FibroGen Inc involves considering the yearly range 0.23 - 12.60 and current price 9.71. Many compare 11.10% and 41.75% before placing orders at 9.71 or 10.01. Explore the FGEN price chart live with daily changes.
What are FibroGen Inc stock highest prices?
The highest price of FibroGen Inc in the past year was 12.60. Within 0.23 - 12.60, the stock fluctuated notably, and comparing with 9.02 helps spot resistance levels. Track FibroGen Inc performance using the live chart.
What are FibroGen Inc stock lowest prices?
The lowest price of FibroGen Inc (FGEN) over the year was 0.23. Comparing it with the current 9.71 and 0.23 - 12.60 shows potential long-term entry points. Watch FGEN moves on the chart live for more details.
When did FGEN stock split?
FibroGen Inc has gone through stock splits historically. These changes are visible in , 9.02, and 2057.78% after corporate actions.
- Previous Close
- 9.02
- Open
- 9.23
- Bid
- 9.71
- Ask
- 10.01
- Low
- 9.23
- High
- 9.75
- Volume
- 79
- Daily Change
- 7.65%
- Month Change
- 11.10%
- 6 Months Change
- 41.75%
- Year Change
- 2057.78%
- Act
- Fcst
- -1.4
- Prev
- 7.7
- Act
- Fcst
- Prev